Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Transcriptomics Market, by Technology
1.4.2 Global Transcriptomics Market, by Application
1.4.3 Global Transcriptomics Market, by Component
1.4.4 Global Transcriptomics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players
Chapter 4. Global Transcriptomics Market by Technology
4.1 Global q PCR Market by Region
4.2 Global Microarrays Market by Region
4.3 Global Sequencing Technology Market by Region
Chapter 5. Global Transcriptomics Market by Application
5.1 Global Drug Discovery Market by Region
5.2 Global Diagnostics & Disease Profiling Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Transcriptomics Market by Component
6.1 Global Consumables Market by Region
6.2 Global Instruments Market by Region
6.3 Global Software Market by Region
6.4 Global Services Market by Region
Chapter 7. Global Transcriptomics Market by Region
7.1 North America Transcriptomics Market
7.1.1 North America Transcriptomics Market by Technology
7.1.1.1 North America q PCR Market by Country
7.1.1.2 North America Microarrays Market by Country
7.1.1.3 North America Sequencing Technology Market by Country
7.1.2 North America Transcriptomics Market by Application
7.1.2.1 North America Drug Discovery Market by Country
7.1.2.2 North America Diagnostics & Disease Profiling Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America Transcriptomics Market by Component
7.1.3.1 North America Consumables Market by Country
7.1.3.2 North America Instruments Market by Country
7.1.3.3 North America Software Market by Country
7.1.3.4 North America Services Market by Country
7.1.4 North America Transcriptomics Market by Country
7.1.4.1 US Transcriptomics Market
7.1.4.1.1 US Transcriptomics Market by Technology
7.1.4.1.2 US Transcriptomics Market by Application
7.1.4.1.3 US Transcriptomics Market by Component
7.1.4.2 Canada Transcriptomics Market
7.1.4.2.1 Canada Transcriptomics Market by Technology
7.1.4.2.2 Canada Transcriptomics Market by Application
7.1.4.2.3 Canada Transcriptomics Market by Component
7.1.4.3 Mexico Transcriptomics Market
7.1.4.3.1 Mexico Transcriptomics Market by Technology
7.1.4.3.2 Mexico Transcriptomics Market by Application
7.1.4.3.3 Mexico Transcriptomics Market by Component
7.1.4.4 Rest of North America Transcriptomics Market
7.1.4.4.1 Rest of North America Transcriptomics Market by Technology
7.1.4.4.2 Rest of North America Transcriptomics Market by Application
7.1.4.4.3 Rest of North America Transcriptomics Market by Component
7.2 Europe Transcriptomics Market
7.2.1 Europe Transcriptomics Market by Technology
7.2.1.1 Europe q PCR Market by Country
7.2.1.2 Europe Microarrays Market by Country
7.2.1.3 Europe Sequencing Technology Market by Country
7.2.2 Europe Transcriptomics Market by Application
7.2.2.1 Europe Drug Discovery Market by Country
7.2.2.2 Europe Diagnostics & Disease Profiling Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe Transcriptomics Market by Component
7.2.3.1 Europe Consumables Market by Country
7.2.3.2 Europe Instruments Market by Country
7.2.3.3 Europe Software Market by Country
7.2.3.4 Europe Services Market by Country
7.2.4 Europe Transcriptomics Market by Country
7.2.4.1 Germany Transcriptomics Market
7.2.4.1.1 Germany Transcriptomics Market by Technology
7.2.4.1.2 Germany Transcriptomics Market by Application
7.2.4.1.3 Germany Transcriptomics Market by Component
7.2.4.2 UK Transcriptomics Market
7.2.4.2.1 UK Transcriptomics Market by Technology
7.2.4.2.2 UK Transcriptomics Market by Application
7.2.4.2.3 UK Transcriptomics Market by Component
7.2.4.3 France Transcriptomics Market
7.2.4.3.1 France Transcriptomics Market by Technology
7.2.4.3.2 France Transcriptomics Market by Application
7.2.4.3.3 France Transcriptomics Market by Component
7.2.4.4 Russia Transcriptomics Market
7.2.4.4.1 Russia Transcriptomics Market by Technology
7.2.4.4.2 Russia Transcriptomics Market by Application
7.2.4.4.3 Russia Transcriptomics Market by Component
7.2.4.5 Spain Transcriptomics Market
7.2.4.5.1 Spain Transcriptomics Market by Technology
7.2.4.5.2 Spain Transcriptomics Market by Application
7.2.4.5.3 Spain Transcriptomics Market by Component
7.2.4.6 Italy Transcriptomics Market
7.2.4.6.1 Italy Transcriptomics Market by Technology
7.2.4.6.2 Italy Transcriptomics Market by Application
7.2.4.6.3 Italy Transcriptomics Market by Component
7.2.4.7 Rest of Europe Transcriptomics Market
7.2.4.7.1 Rest of Europe Transcriptomics Market by Technology
7.2.4.7.2 Rest of Europe Transcriptomics Market by Application
7.2.4.7.3 Rest of Europe Transcriptomics Market by Component
7.3 Asia Pacific Transcriptomics Market
7.3.1 Asia Pacific Transcriptomics Market by Technology
7.3.1.1 Asia Pacific q PCR Market by Country
7.3.1.2 Asia Pacific Microarrays Market by Country
7.3.1.3 Asia Pacific Sequencing Technology Market by Country
7.3.2 Asia Pacific Transcriptomics Market by Application
7.3.2.1 Asia Pacific Drug Discovery Market by Country
7.3.2.2 Asia Pacific Diagnostics & Disease Profiling Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Transcriptomics Market by Component
7.3.3.1 Asia Pacific Consumables Market by Country
7.3.3.2 Asia Pacific Instruments Market by Country
7.3.3.3 Asia Pacific Software Market by Country
7.3.3.4 Asia Pacific Services Market by Country
7.3.4 Asia Pacific Transcriptomics Market by Country
7.3.4.1 China Transcriptomics Market
7.3.4.1.1 China Transcriptomics Market by Technology
7.3.4.1.2 China Transcriptomics Market by Application
7.3.4.1.3 China Transcriptomics Market by Component
7.3.4.2 Japan Transcriptomics Market
7.3.4.2.1 Japan Transcriptomics Market by Technology
7.3.4.2.2 Japan Transcriptomics Market by Application
7.3.4.2.3 Japan Transcriptomics Market by Component
7.3.4.3 India Transcriptomics Market
7.3.4.3.1 India Transcriptomics Market by Technology
7.3.4.3.2 India Transcriptomics Market by Application
7.3.4.3.3 India Transcriptomics Market by Component
7.3.4.4 South Korea Transcriptomics Market
7.3.4.4.1 South Korea Transcriptomics Market by Technology
7.3.4.4.2 South Korea Transcriptomics Market by Application
7.3.4.4.3 South Korea Transcriptomics Market by Component
7.3.4.5 Singapore Transcriptomics Market
7.3.4.5.1 Singapore Transcriptomics Market by Technology
7.3.4.5.2 Singapore Transcriptomics Market by Application
7.3.4.5.3 Singapore Transcriptomics Market by Component
7.3.4.6 Malaysia Transcriptomics Market
7.3.4.6.1 Malaysia Transcriptomics Market by Technology
7.3.4.6.2 Malaysia Transcriptomics Market by Application
7.3.4.6.3 Malaysia Transcriptomics Market by Component
7.3.4.7 Rest of Asia Pacific Transcriptomics Market
7.3.4.7.1 Rest of Asia Pacific Transcriptomics Market by Technology
7.3.4.7.2 Rest of Asia Pacific Transcriptomics Market by Application
7.3.4.7.3 Rest of Asia Pacific Transcriptomics Market by Component
7.4 LAMEA Transcriptomics Market
7.4.1 LAMEA Transcriptomics Market by Technology
7.4.1.1 LAMEA q PCR Market by Country
7.4.1.2 LAMEA Microarrays Market by Country
7.4.1.3 LAMEA Sequencing Technology Market by Country
7.4.2 LAMEA Transcriptomics Market by Application
7.4.2.1 LAMEA Drug Discovery Market by Country
7.4.2.2 LAMEA Diagnostics & Disease Profiling Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA Transcriptomics Market by Component
7.4.3.1 LAMEA Consumables Market by Country
7.4.3.2 LAMEA Instruments Market by Country
7.4.3.3 LAMEA Software Market by Country
7.4.3.4 LAMEA Services Market by Country
7.4.4 LAMEA Transcriptomics Market by Country
7.4.4.1 Brazil Transcriptomics Market
7.4.4.1.1 Brazil Transcriptomics Market by Technology
7.4.4.1.2 Brazil Transcriptomics Market by Application
7.4.4.1.3 Brazil Transcriptomics Market by Component
7.4.4.2 Argentina Transcriptomics Market
7.4.4.2.1 Argentina Transcriptomics Market by Technology
7.4.4.2.2 Argentina Transcriptomics Market by Application
7.4.4.2.3 Argentina Transcriptomics Market by Component
7.4.4.3 UAE Transcriptomics Market
7.4.4.3.1 UAE Transcriptomics Market by Technology
7.4.4.3.2 UAE Transcriptomics Market by Application
7.4.4.3.3 UAE Transcriptomics Market by Component
7.4.4.4 Saudi Arabia Transcriptomics Market
7.4.4.4.1 Saudi Arabia Transcriptomics Market by Technology
7.4.4.4.2 Saudi Arabia Transcriptomics Market by Application
7.4.4.4.3 Saudi Arabia Transcriptomics Market by Component
7.4.4.5 South Africa Transcriptomics Market
7.4.4.5.1 South Africa Transcriptomics Market by Technology
7.4.4.5.2 South Africa Transcriptomics Market by Application
7.4.4.5.3 South Africa Transcriptomics Market by Component
7.4.4.6 Nigeria Transcriptomics Market
7.4.4.6.1 Nigeria Transcriptomics Market by Technology
7.4.4.6.2 Nigeria Transcriptomics Market by Application
7.4.4.6.3 Nigeria Transcriptomics Market by Component
7.4.4.7 Rest of LAMEA Transcriptomics Market
7.4.4.7.1 Rest of LAMEA Transcriptomics Market by Technology
7.4.4.7.2 Rest of LAMEA Transcriptomics Market by Application
7.4.4.7.3 Rest of LAMEA Transcriptomics Market by Component
Chapter 8. Company Profiles
8.1 Fluidigm Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.2 Promega Corporation
8.2.1 Company Overview
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Merck & Co., Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Thermo Fisher Scientific, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Illumina, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.8 Agilent Technologies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Qiagen N.V.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Acquisition and Mergers:
Unique Offerings 